AI Article Synopsis
- The study focuses on patients diagnosed with multiple myeloma, aiming to understand its correlation with mortality rates.
- Conducted at a medical school, the research analyzed patient data from 2006 to 2010, revealing a median age of 58.5 years, high rates of anemia (87%) and significant creatinine levels (19%).
- Findings indicate a five-year survival rate of 74.6%, with Durie-Salmon staging showing a significant link to patient outcomes, while other staging systems did not have a notable impact on survival rates.
Article Abstract
Objective: To present a descriptive analysis of patients diagnosed with multiple myeloma, correlating it with mortality.
Methods: A retrospective study that analyzed consecutive patients diagnosed with multiple myeloma under follow-up at the Faculdade de Medicina do ABC from 2006 to 2010.
Results: The median age was 58.5 years. Anemia was observed upon diagnosis in 87% of patients, hypercalcemia in 38%, and creatinine levels higher than 2 mg/dL in 19%. M protein was detected in 85.7%. The five-year survival rate was 74.6%. Multivariate analysis showed statistical significance for Durie-Salmon staging (p = 0.037). The International Staging System and immunoglobulin type did not correlate significantly with survival of the group.
Conclusion: This set of cases from a tertiary public healthcare service reflect the approach of multiple myeloma in a predominantly young population with advanced clinical staging, with results comparable to those of the literature.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1590/S1679-45082011AO2006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!